Red Eye, Global Challenge - Takeaways - MDSpire

Red Eye, Global Challenge

Narrative review calls for clearer guidance on noninfectious conjunctival hyperemia

  • March 18, 2026

  • 2 min

Share

  • 1

    Noninfectious conjunctival hyperemia is a growing global issue, driven by lifestyle factors like digital eye strain and pollution.

  • 2

    Dry eye disease and ocular allergy are leading causes of chronic redness, affecting significant portions of the population.

  • 3

    Current management often relies on over-the-counter drops, but traditional decongestants have limitations like tachyphylaxis.

  • 4

    Low-dose brimonidine 0.025% shows promise for redness reduction without tachyphylaxis, but long-term data is needed.

  • 5

    There is a critical need for dedicated management guidelines and better patient education to address conjunctival hyperemia.

Original Source(s)

Red Eye, Global Challenge

  • March 18, 2026

Related Content

The Importance of Treating OSD and Lid Margin Disease Preoperatively

Marjan Farid, MD, discusses her ASCRS Cornea Day presentation on preoperatively treating DED and OSD.

  • April 11, 2026

  • 4 min
Elevating Ocular Surface Care

The trilayer decellularized basement membrane is used in ocular surgery and in OSD applications, including corneal and conjunctival-related injuries or defects.

When Vision Fluctuates, Look to the Tear Film First

Dr. Theriot discusses the differences between natural tear film and artificial tears—and why the change in moniker to "lubricating drops" is appropriate.